An interventional study of PRESS AI-Supported Nursing Care in Pressure Injury, sponsored by Ankara Yildirim Beyazıt University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-21.
Sponsored by Ankara Yildirim Beyazıt University · Not applicable, Interventional, and Prevention
This study evaluates the effect of an artificial intelligence-supported mobile application, PRESS AI, on pressure injury prevention and nursing care in adult intensive care patients. The application supports nurses in pressure injury risk assessment, wound assessment and staging, and selection of appropriate prevention and care interventions. The study compares the incidence of hospital-acquired pressure injuries before and after the implementation of PRESS AI. During the pre-intervention period, patients receive routine pressure injury prevention and nursing care. During the intervention period, nurses use PRESS AI together with an integrated pressure injury prevention and care algorithm to support clinical assessment and care planning.
This interventional before-and-after study is conducted in the Anesthesiology and Reanimation Intensive Care Unit of Ankara University Ibni Sina Research and Application Hospital. Adult patients meeting the eligibility criteria are included during the pre-intervention and intervention periods.
The pre-intervention period is conducted from March 1, 2026, to May 31, 2026. During this period, pressure injury risk assessment, skin assessment, prevention, and nursing care are performed according to routine clinical practice. PRESS AI is not used during this period.
Following a training and implementation period in June 2026, PRESS AI is introduced into clinical practice. The intervention period is conducted from July 1, 2026, to September 30, 2026. PRESS AI incorporates Braden Scale risk assessment, skin and wound assessment, artificial intelligence-supported image analysis for pressure injury staging, and a pressure injury prevention and care algorithm to support nursing care planning.
The artificial intelligence-generated staging recommendation is used as clinical decision support and does not replace the nurse's clinical judgment. The final pressure injury stage is determined by the nurse. Patients are followed daily for the development of new pressure injuries during their intensive care stay. The incidence of hospital-acquired pressure injuries during the pre-intervention and intervention periods is compared to evaluate the effectiveness of the PRESS AI-supported approach.
545 studies on the registry are indexed under Pressure Ulcer; 129 are open to participants now.
This study's planned enrollment of 174 is above the median of 70 across 405 interventional studies indexed under Pressure Ulcer.
Browse Pressure Ulcer studies →Ankara Yildirim Beyazıt University is the lead sponsor of 241 studies on the registry; 54 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this arm receive routine pressure injury prevention and nursing care according to standard clinical practice. Pressure injury risk and skin assessments are performed using routine clinical procedures. The PRESS AI mobile application and its integrated pressure injury prevention and care algorithm are not used in this arm.
Participants in this arm receive pressure injury prevention and nursing care supported by the PRESS AI mobile application and its integrated pressure injury prevention and care algorithm. PRESS AI supports pressure injury risk assessment, skin and wound assessment, artificial intelligence-assisted pressure injury staging, and planning of prevention and care interventions. The final pressure injury staging decision is made by the nurse based on clinical assessment.
Other: PRESS AI-Supported Nursing Care
PRESS AI is an artificial intelligence-supported mobile clinical decision support application integrated with a pressure injury prevention and care algorithm. It supports nurses in Braden Scale risk assessment, skin and wound assessment, artificial intelligence-assisted pressure injury staging, and the planning and documentation of individualized pressure injury prevention and care interventions. Artificial intelligence-generated staging recommendations are used to support clinical decision-making and do not replace nurses' clinical judgment. The final pressure injury stage is determined by the nurse based on clinical assessment.
Incidence of Hospital-Acquired Pressure Injuries
The incidence of hospital-acquired pressure injuries will be determined based on newly developed pressure injuries during the intensive care unit stay. Patients will be assessed daily for pressure injury development, including the date of occurrence, anatomical location, and stage. The incidence during the pre-intervention period will be compared with the incidence during the PRESS AI intervention period.
Time frame: Daily during each participant's intensive care unit stay; assessed over the 3-month pre-intervention period (March 1-May 31, 2026) and the 3-month intervention period (July 1-September 30, 2026).
Distribution of Pressure Injury Stages
Newly developed hospital-acquired pressure injuries will be classified according to pressure injury stage. The number and proportion of pressure injuries in each stage will be determined and compared between the pre-intervention and PRESS AI intervention periods.
Time frame: Daily during each participant's intensive care unit stay; assessed over the 3-month pre-intervention period (March 1-May 31, 2026) and the 3-month intervention period (July 1-September 30, 2026).
Anatomical Distribution of Pressure Injuries
The anatomical locations of newly developed hospital-acquired pressure injuries will be recorded. The number and proportion of pressure injuries according to anatomical location will be determined and compared between the pre-intervention and PRESS AI intervention periods.
Time frame: Daily during each participant's intensive care unit stay; assessed over the 3-month pre-intervention period (March 1-May 31, 2026) and the 3-month intervention period (July 1-September 30, 2026).
Time to Development of Pressure Injury
The time from admission to the intensive care unit to the development of a new hospital-acquired pressure injury will be recorded in days for patients who develop a pressure injury. The time to pressure injury development will be evaluated and compared between the pre-intervention and PRESS AI intervention periods.
Time frame: From intensive care unit admission until the first occurrence of a hospital-acquired pressure injury or intensive care unit discharge, whichever occurs first, during the 3-month pre-intervention and 3-month intervention periods.
Plan to share: No — Individual participant data sharing is not planned as part of the current study protocol.
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ankara Yildirim Beyazıt University →